Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Nautilus Biotechnology, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 88 | 2 | 88 | +2 |
| Shares | 63.9M | 216.4K | 62.8M | −877.8K (−1.4%) |
| Value | $107.3M | $363.5K | $54.0M | −$52.9M (−49.5%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 225,098 | $193.8K | 0.00% |
| Nuveen, LLC | 193,591 | $166.7K | 0.00% |
| Bridgeway Capital Management, LLC | 50,000 | $43.0K | 0.00% |
| Fayez Sarofim & Co | 45,000 | $38.7K | 0.00% |
| XTX Topco Ltd | 35,553 | $30.6K | 0.00% |
| AQR Capital Management LLC | 21,442 | $18.5K | 0.00% |
| Jefferies Financial Group Inc. | 19,287 | $16.6K | 0.00% |
| Gsa Capital Partners LLP | 12,512 | $11.0K | 0.00% |
| CIBC World Markets Corp | 10,811 | $9.31K | 0.00% |
| CAPROCK Group, Inc. | 10,090 | $8.69K | 0.00% |
| Boston Private Wealth LLC | 5,094 | $4.39K | 0.00% |
| Coldstream Capital Management Inc | 1,412 | $1.22K | 0.00% |
| Russell Investments Group, Ltd. | 178 | $153 | 0.00% |
| True Wealth Design, LLC | 12 | $11 | 0.00% |
Sold out (12)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Signaturefd, LLC | 37,313 | $62.7K |
| Cubist Systematic Strategies, LLC | 20,256 | $34.0K |
| Virtu Financial LLC | 16,604 | $28.0K |
| Northstar Advisory Group, LLC | 14,515 | $24.4K |
| Manufacturers Life Insurance Company, The | 14,357 | $24.1K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13,692 | $23.0K |
| Elser Financial Planning, Inc | 10,000 | $16.8K |
| Point72 (DIFC) Ltd | 1,841 | $3.09K |
| Comerica Bank | 1,209 | $2.03K |
| Eagle Bay Advisors LLC | 337 | $566 |
| CIBC Private Wealth Group, LLC | 200 | $364 |
| IFP Advisors, Inc | 5 | $8 |
Not filed for Q1 2025 yet (2)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 193,591 | $325.2K |
| Lake Street Advisors Group, LLC | 22,762 | $38.2K |